Oncotype DX: Where Does It Stand in India?

被引：14

作者：

Batra, Atul ^{[1
]}

Patel, Amol ^{[2
]}

Gupta, Vineet Govinda ^{[3
]}

Mehta, Prashant ^{[4
]}

Tvsvgk, Tilak ^{[5
]}

Biswas, Bivas ^{[6
]}

Pramanik, Raja ^{[1
]}

Das, Chandan Krishnan ^{[7
]}

Srivastava, Priyanka ^{[8
]}

机构：

[1] All India Inst Med Sci, New Delhi, India

[2] Army Hosp Res & Referral, New Delhi, India

[3] Artemis Hosp, Gurugram, India

[4] Asian Inst Med Sci, Faridabad, India

[5] Armed Forces Med Coll, Pune, Maharashtra, India

[6] Tata Med Ctr, Kolkata, India

[7] Post Grad Inst Med Educ & Res, Chandigarh, India

[8] HM Patel Canc Ctr, Karamsad, India

来源：

JOURNAL OF GLOBAL ONCOLOGY | 2019年 / 5卷

关键词：

BREAST; CHEMOTHERAPY; EXPRESSION; ASSAY;

D O I：

10.1200/JGO.19.00151

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 12 条

[1] Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Allemani, Claudia
Weir, Hannah K.
Carreira, Helena
Harewood, Rhea
Spika, Devon
Wang, Xiao-Si
Bannon, Finian
Ahn, Jane V.
Johnson, Christopher J.
Bonaventure, Audrey
Marcos-Gragera, Rafael
Stiller, Charles
Azevedo e Silva, Gulnar
Chen, Wan-Qing
Ogunbiyi, Olufemi J.
Rachet, Bernard
Soeberg, Matthew J.
You, Hui
Matsuda, Tomohiro
Bielska-Lasota, Magdalena
Storm, Hans
Tucker, Thomas C.
Coleman, Michel P.
[J]. LANCET, 2015, 385 (9972) : 977 - 1010
[2] Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
Anders, Carey K.
Hsu, David S.
Broadwater, Gloria
Acharya, Chaitanya R.
Foekens, John A.
Zhang, Yi
Wang, Yixin
Marcom, P. Kelly
Marks, Jeffrey R.
Febbo, Phillip G.
Nevins, Joseph R.
Potti, Anil
Blackwell, Kimberly L.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) : 3324 - 3330
[3] Chopra R, 2001, J CLIN ONCOL, V19, p106S
[4] Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
Fredholm, Hanna
Eaker, Sonja
Frisell, Jan
Holmberg, Lars
Fredriksson, Irma
Lindman, Henrik
[J]. PLOS ONE, 2009, 4 (11): : A38 - A46
[5] Estimating regimen-specific costs of chemotherapy for breast cancer: Observational cohort study
Giordano, Sharon H.
Niu, Jiangong
Chavez-MacGregor, Mariana
Zhao, Hui
Zorzi, Daria
Shih, Ya-Chen Tina
Smith, Benjamin D.
Shen, Chan
[J]. CANCER, 2016, 122 (22) : 3447 - 3455
[6] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
Paik, S
Shak, S
Tang, G
Kim, C
Baker, J
Cronin, M
Baehner, FL
Walker, MG
Watson, D
Park, T
Hiller, W
Fisher, ER
Wickerham, DL
Bryant, J
Wolmark, N
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) : 2817 - 2826
[7] Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Paik, Soonmyung
Tang, Gong
Shak, Steven
Kim, Chungyeul
Baker, Joffre
Kim, Wanseop
Cronin, Maureen
Baehner, Frederick L.
Watson, Drew
Bryant, John
Costantino, Joseph P.
Geyer, Charles E., Jr.
Wickerham, D. Lawrence
Wolmark, Norman
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (23) : 3726 - 3734
[8] Profile of breast cancer patients at a tertiary care hospital in north India
Sandhu, D. S.
Sandhu, S.
Karwasra, R. K.
Marwah, S.
[J]. INDIAN JOURNAL OF CANCER, 2010, 47 (01) : 16 - 22
[9] Sandhu Gurprataap S, 2016, J Glob Oncol, V2, P412, DOI 10.1200/JGO.2016.005397
[10] Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India - A cross-sectional study
Saxena S.
Rekhi B.
Bansal A.
Bagga A.
Chintamani
Murthy N.S.
[J]. World Journal of Surgical Oncology, 3 (1)

← 1 2 →